BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 2, 2017
View Archived Issues
BTK inhibitors presented by Corvus Pharmaceuticals
Read More
Safety and tolerability good with AZD-8871 in first-in-human study
Read More
Lutathera approved in Europe
Read More
FDA approves Novo Nordisk's Fiasp
Read More
KLF2 gene mutation linked to heritable pulmonary arterial hypertension
Read More
CSIR describes novel anticancer podophyllotoxin derivatives
Read More
CTxT Pty identifies new protein arginine N-methyltransferase 5 inhibitors
Read More
COLEC11, a possible therapeutic target for treating renal ischemia reperfusion injury
Read More
Japanese authorities approve Vizamyl for diagnosis of Alzheimer's
Read More
The University of Texas patents PTP-2C inhibitors
Read More
LRRK2 inhibitors reported in Denali Therapeutics patent
Read More
AstraZeneca presents new PI3Kgamma inhibitors
Read More
Merck & Co. discontinues development of two HCV drugs
Read More
ViaCyte obtains another CIRM grant to support development of PEC-Direct product candidate
Read More
Ruconest provides clinically meaningful relief of symptons in phase II study
Read More
MD Anderson and Pfizer collaborate to study combinations of Pfizer compounds in cancer
Read More
Valeant Pharmaceuticals completes sale of iNova Pharmaceuticals
Read More
Gene expression in blood shown to predict bronchiolitis obliterans after lung transplantation
Read More
AbbVie's A-485 potently inhibits CREB-binding protein and histone acetyltransferase p300
Read More
Radius Health enrolls first patient in phase I study of RAD-140 for breast cancer
Read More
U.K.'s MHRA grants PIM designation to Traumakine for acute respiratory distress syndrome
Read More
Takeda, Karolinska Institutet and SGC enter IBD collaboration
Read More
National Multiple Sclerosis Society supports preclinical studies of TG Therapeutics' TGR-1202
Read More
Indivior submits NDA for RBP-7000 for schizophrenia
Read More
NCI grant to support phase II trial of NVX-108 for glioblastoma multiforme
Read More
JCR seeks Japanese approval for JR-051 for Fabry disease
Read More
Zogenix reports promising topline results from first pivotal trial of ZX-008 in Dravet syndrome
Read More
Ablynx reports phase III results for caplacizumab in aTTP
Read More